Stay Informed on Key Developments

Investor News and Updates

Bill_Ipad

Stay informed about key developments at our company as they happen. Discover our Ad-Hoc Releases and subscribe to our newsletter to receive the latest news and topics of interest.

381 - 390of 392 News
381 - 390of 392 News
September 12, 2017
Wolfgang Nickl to be new Chief Financial Officer at Bayer AG
READ MORE
September 07, 2017
Not intended for U.S. and UK Media
Bayer submits marketing authorization application for BAY94-9027 for the treatment of Hemophilia A in the EU
READ MORE
August 31, 2017
Not intended for U.S. and UK Media
Bayer submits Biologics License Application in the U.S. for BAY94-9027 - a long-acting factor VIII for the treatment of Hemophilia A
READ MORE
August 30, 2017
Not intended for U.S. and UK Media - 17th European Society of Retina Specialists (EURETINA) Congress
Bayer to showcase latest Ophthalmology research at EURETINA 2017
READ MORE
August 27, 2017
Not intended for U.S. and UK Media - Data from COMPASS study, including 27,395 patients, presented at ESC Congress 2017:
Bayer’s Xarelto® significantly lowered the combined risk of stroke, cardiovascular death and heart attack in patients with chronic coronary or peripheral artery disease by 24%
READ MORE
August 22, 2017
Phase II investigation of the proposed combination of Bayer and Monsanto:
Bayer will continue to work constructively with the European Commission
READ MORE
August 21, 2017
Not intended for U.S. and UK Media
Two abstracts on Phase III COMPASS study with Bayer’s Rivaroxaban accepted for presentation in Hot Line sessions at ESC Congress 2017
READ MORE
August 07, 2017
Not intended for U.S. and UK Media
Bayer Receives EU Approval for Stivarga® (Regorafenib) for the Second-Line Systemic Treatment of Liver Cancer
READ MORE
July 27, 2017
Second quarter of 2017:
Bayer: Group performance matches prior year despite declines at Crop Science
READ MORE
July 21, 2017
Not intended for U.S. and UK Media
Phase II Trial of Investigational Anetumab Ravtansine Does Not Meet Primary Endpoint in Second-Line Mesothelioma
READ MORE
381 - 390of 392 News
381 - 390of 392 News
Inform Yourself on Special Topics
Control Weeds Not Farming

Control Weeds, Not Farming

LEARN MORE
Farmers discussing their weed management

Everything You Need to Know About Glyphosate

LEARN MORE
some-bayer-group-headquarters

Managing Glyphosate Litigation

learn more
woman harvesting carrots

Managing and Mitigating PCB Litigation Risk

learn more